Development of novel CRISPR-Cas9 protein scaffolds and base editors - engineering a smaller SpCas9
CRISPR-Cas system holds immense potential for treatment of genetic diseases. However, therapeutic adoption of CRISPR-Cas9 system still faces issues with safety and efficient delivery in vivo. Gene editing with Cas9 can potentially treat genetic diseases at its root cause. However, this classically r...
Main Author: | Teo, Danny Shun Xiang |
---|---|
Other Authors: | Tan Meng How |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/181295 |
Similar Items
-
Optimizing Systems for Cas9 Expression in Toxoplasma gondii
by: Markus, Benedikt M., et al.
Published: (2020) -
Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells
by: Zheng, Qiupeng, et al.
Published: (2019) -
Localized delivery of CRISPR/dCas9 via layer-by-layer self-assembling peptide coating on nanofibers for neural tissue engineering
by: Zhang, Kunyu, et al.
Published: (2020) -
A newly discovered Bordetella species carries a transcriptionally active CRISPR-Cas with a small Cas9 endonuclease
by: Ivanov, Yury V., et al.
Published: (2015) -
Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing
by: Chin, Jiah Shin, et al.
Published: (2020)